Zepto Life Technology Achieves CAP Accreditation for Its Innovative FungiFlex® Testing Services

Zepto Life Technology Achieves CAP Accreditation for FungiFlex® Testing



Zepto Life Technology, a leader in molecular diagnostics, has recently announced its clinical laboratory's receipt of accreditation from the College of American Pathologists (CAP) as of November 14, 2026. This esteemed recognition marks a significant achievement in laboratory standards and underscores the company's commitment to quality and patient care.

Importance of CAP Accreditation



The CAP accreditation is a well-respected benchmark for laboratory quality, ensuring that labs meet rigorous standards across all aspects of testing operations. These include personnel qualifications, equipment standards, facilities adequacy, safety, and quality management systems. As Hannah Zhang, CEO of Zepto Life Technology, stated, "Behind every specimen is a patient waiting for answers. The quality of our work matters to that patient and the clinicians caring for them. CAP accreditation recognizes the standards our laboratory team works hard to uphold every day."

The FungiFlex® Testing Menu



Zepto Life Technology offers the innovative FungiFlex® menu, designed to provide targeted plasma cell-free DNA (cfDNA) tests for diagnosing invasive fungal infections. The tests are particularly beneficial for patients with weakened immune systems, such as transplant recipients or individuals diagnosed with hematologic malignancies. Results from these tests can be delivered in under 24 hours after sample collection, significantly expediting patient care decisions.

The FungiFlex® suite includes several key tests:
  • - Mold Panel: Detects fourteen different clinically significant mold species.
  • - Pneumocystis jirovecii Testing: Targets a specific type of fungal infection highly relevant in immunocompromised individuals.
  • - Mold Plus Panel: Combines both the Mold Panel and targeted Pneumocystis testing, providing comprehensive diagnostic capabilities.

These laboratory-developed tests operate through Zepto's CLIA-certified reference lab, highlighting the company's commitment to providing high-quality, actionable diagnostics in the field of infectious diseases.

The Role of FungiFlex® in Modern Healthcare



Invasive fungal infections pose a significant challenge in modern healthcare, particularly for at-risk populations. By using FungiFlex®, healthcare providers can gather organism-level information from a standard blood draw, enabling them to make informed treatment decisions. This approach not only improves patient outcomes but also enhances the overall efficiency of clinical operations.

Zepto Life Technology continues to advance its offerings in the area of molecular diagnostics, aiming to integrate plasma cfDNA liquid biopsy testing into routine practice for infectious diseases. Their ongoing development of the Zepto MDx™ platform is aimed at facilitating sample-to-result liquid biopsy testing directly within hospital and clinical microbiology settings, further streamlining the diagnostic process.

The accreditation by CAP not only reaffirms Zepto Life Technology's dedication to maintaining high quality in its laboratory services but also opens pathways for expanded access and use of its advanced testing methodologies in healthcare institutions.

For further information about the FungiFlex® testing options and ordering resources, healthcare professionals and interested parties are encouraged to visit zeptolife.com/reference-lab-testing. This resource will provide valuable insights and practical guidelines for utilizing the company’s significant advancements in diagnostic testing.

Conclusion



With its CAP accreditation, Zepto Life Technology stands at the forefront of innovation in the diagnostic testing landscape, particularly for fungal infections that critically affect immunocompromised patients. As healthcare continues to evolve towards precision medicine, Zepto's contributions highlight the importance of accessibility to high-quality diagnostic tools that can lead to improved patient care and clinical outcomes.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.